Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers

NCT03568578 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03568578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03568578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 28, 2018
Completion date
September 30, 2021
Enrollment
450 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, liver fibrosis